News
ACCD
3.710
+4.21%
0.150
TransUnion Stock Gains 27% in the Past 6 Months: Here's Why
NASDAQ · 1d ago
Weekly Report: what happened at ACCD last week (1111-1115)?
Weekly Report · 3d ago
Weekly Report: what happened at ACCD last week (1104-1108)?
Weekly Report · 11/11 09:02
Weekly Report: what happened at ACCD last week (1028-1101)?
Weekly Report · 11/04 09:02
Accolade And 2 Other Penny Stocks To Watch On US Exchanges
Simply Wall St · 10/31 20:04
Weekly Report: what happened at ACCD last week (1021-1025)?
Weekly Report · 10/28 09:02
Form 10-Q for the quarterly period ended August 31, 2024
Press release · 10/26 08:37
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
NASDAQ · 10/24 13:35
Weekly Report: what happened at ACCD last week (1014-1018)?
Weekly Report · 10/21 09:02
Weekly Report: what happened at ACCD last week (1007-1011)?
Weekly Report · 10/14 09:02
Accolade Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 10/11 13:14
Accolade Price Target Cut to $6.00/Share From $7.00 by Wells Fargo
Dow Jones · 10/11 13:14
Wells Fargo Maintains Equal-Weight on Accolade, Lowers Price Target to $6
Benzinga · 10/11 13:04
ACCOLADE, INC. <ACCD.O>: WELLS FARGO CUTS TARGET PRICE TO $6 FROM $7
Reuters · 10/11 11:14
Accolade price target lowered to $6 from $7 at Wells Fargo
TipRanks · 10/11 10:40
Accolade Financial Analysis: A Hold Rating Amid Revenue Growth Uncertainties and Operational Challenges
TipRanks · 10/11 08:55
U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Deere & Co, Zoetis
Reuters · 10/11 07:47
U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku
Reuters · 10/10 06:39
ACCOLADE INC <ACCD.O>: RAYMOND JAMES CUTS TARGET PRICE TO $7 FROM $11
Reuters · 10/10 04:02
Accolade’s Strong Financial Performance and Positive Future Outlook Justify Buy Rating
TipRanks · 10/10 02:45
More
Webull provides a variety of real-time ACCD stock news. You can receive the latest news about Accolade, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ACCD
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.